Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy

NCT02138253 is registered in ClinicalTrials.gov with Conatus Pharmaceuticals Inc. as lead sponsor.

NCT NCT02138253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02138253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Double-Blind, Randomized Trial of IDN-6556 in Subjects Who Had Hepatitis C Virus (HCV) Reinfection and Liver Fibrosis Following Orthotopic Liver Transplantation for Chronic HCV Infection and Who Subsequently Achieved a Sustained Virologic Response Following Anti-HCV Therapy
Lead sponsor
Conatus Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2014
Completion date
March 9, 2018
Enrollment
64 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic cirrhosis, hepatic fibrosis, liver cirrhosis, liver fibrosis